Search

everythinglearnresearchcommunity

for

Search:↓

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Microneedling, PRP therapy, and pharmacological treatments show promise for hair loss, but more research is needed.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Eating grape powder may reduce the severity of skin allergy symptoms.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

PCOS has many symptoms, with high androgen levels being the most common.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.